Cingulate Inc. (NASDAQ: CING) is making significant strides in its development of CTx-1301, a treatment aimed at addressing Attention Deficit Hyperactivity Disorder (ADHD). According to an...
A recent study from the University of Waterloo has provided valuable insights into the effectiveness of COVID-19 vaccines against emerging strains of the virus. Conducted by...
The U.S. Food and Drug Administration (FDA) has announced a significant recall of more than 580,000 bottles of the blood pressure medication prazosin hydrochloride. This action...
The U.S. Food and Drug Administration (FDA) has announced a significant recall affecting over 580,000 bottles of the blood pressure medication prazosin hydrochloride. The recall, initiated...
Akebia Therapeutics has announced it will discontinue its efforts to expand the use of Vafseo (vadadustat) for treating anemia in patients with chronic kidney disease (CKD)...
The U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to Elanco Animal Health for its product Credelio (active ingredient: lotilaner). This authorization...
atai Life Sciences and Beckley Psytech have been granted Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) for their investigational nasal spray, BPL-003,...
September 2025 has showcased a remarkable selection of eco-friendly designs that blend sustainability with style and functionality. These innovative products demonstrate that environmental consciousness can be...
